aid: neurona-therapeutics
name: Neurona Therapeutics
description: >-
  Neurona Therapeutics is a clinical-stage biotherapeutics company in South San Francisco, California,
  developing allogeneic regenerative neural cell therapies that permanently integrate into neural
  circuits to treat chronic disorders of the nervous system. Founded on nearly two decades of stem cell
  research from the University of California, San Francisco, its lead candidate NRTX-1001 (rezanecel) is
  an inhibitory interneuron cell therapy delivered as a single, minimally invasive dose for drug-resistant
  mesial temporal lobe epilepsy, and is advancing through the NTE001 and NTE002 studies toward the Phase 3
  EPIC trial. UCB completed its acquisition of Neurona on June 2, 2026. The company publishes no public
  API, developer program, SDK, or machine-readable specification; its public surface is corporate and
  clinical, not developer-facing.
url: https://raw.githubusercontent.com/api-evangelist/neurona-therapeutics/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://www.neuronatherapeutics.com/themes/default/images/logo_gray.png
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Cell Therapy
- Regenerative Medicine
- Neurology
- Epilepsy
- Clinical Trials
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/neurona-therapeutics-domain-security.yml
- type: Website
  url: https://www.neuronatherapeutics.com/
- type: About
  url: https://www.neuronatherapeutics.com/about/
- type: Technology
  url: https://www.neuronatherapeutics.com/technology/
- type: Pipeline
  url: https://www.neuronatherapeutics.com/pipeline/
- type: News
  url: https://www.neuronatherapeutics.com/news/press-releases/
- type: Careers
  url: https://www.neuronatherapeutics.com/careers/
- type: Contact
  url: https://www.neuronatherapeutics.com/contact/
- type: TermsOfService
  url: https://www.neuronatherapeutics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.neuronatherapeutics.com/privacy-policy/
- type: ParentCompany
  name: UCB S.A.
  url: https://www.ucb.com
  x-relationship: acquisition
- type: ParentCompanyProfile
  name: UCB in the API Evangelist network
  url: https://github.com/api-evangelist/ucb
- type: AcquisitionAnnouncement
  name: UCB completes acquisition of Neurona Therapeutics (2026-06-02)
  url: https://www.ucb.com/newsroom/press-releases/article/ucb-completes-acquisition-of-neurona-therapeutics-advancing-its-leadership-as-innovator-in-epilepsy-through-regenerative-science
- type: SecondaryMarketListing
  name: Forge Global private-market listing
  url: https://forgeglobal.com/neurona-therapeutics_stock/
- type: Plans
  url: plans/neurona-therapeutics-plans-pricing.yml
- type: RateLimits
  url: rate-limits/neurona-therapeutics-rate-limits.yml
- type: LLMsTxt
  url: llms/neurona-therapeutics-llms.txt

x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 5
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Neurona Therapeutics is a clinical-stage cell-therapy biotech whose product is an injected neural
    cell therapy (NRTX-1001); its corporate site has no developer, API, or data section at all and
    every contract-discovery path probed on www.neuronatherapeutics.com returned a hard 404.
  evidence:
  - url: https://www.neuronatherapeutics.com/openapi.json
    status: 404
  - url: https://www.neuronatherapeutics.com/.well-known/agent-card.json
    status: 404
  - url: https://www.neuronatherapeutics.com/graphql
    status: 404
  - url: https://www.neuronatherapeutics.com/
    status: 200
  checked: '2026-08-26'